Polychemotherapy and the prevention of drug incompatibility
Gogin, E.E.
Klinicheskaia Meditsina 69(8): 3-6
1991
ISSN/ISBN: 0023-2149 PMID: 1791704 Document Number: 380025
Document emailed within 1 workday
Related Documents
Astaf'ev, V.A. 1980: Drug incompatibility Fel'dsher i Akusherka 45(11): 29-30Sheĭnbaum, E.M. 1978: What the nurse should know about drug incompatibility Meditsinskaia Sestra 37(3): 45-48
Apachiţei, A. 1970: Drug incompatibility in pediatric practice Pediatria 19(5): 469-473
Chubarev, V.N. 1990: The incompatibility of antihistamine preparations with other drug agents Meditsinskaia Sestra 49(6): 43-48
Kachala, V.P.; Il'nitskaia, Z.N. 1971: Incompatibility of injectable drug solutions in the same syringe Meditsinskaia Sestra 30(5): 33-36
Seyfriedowa, H.; Lenkiewicz, B.; Dyl, P. 1985: Evaluation of failures in the prevention of Rh incompatibility Ginekologia Polska 56(5-6): 335-341
Slining, J.; Cole, P.; Emmanuel, S. 1970: Development of a drug incompatibility file and its use in patient medication profile reviews American Journal of Hospital Pharmacy 27(6): 459-467
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Bhatt, A.D. 1999: Drug-related problems and adverse drug events: negligence, litigation and prevention Journal of the Association of Physicians of India 47(7): 715-720
Hahn, M.; Braus, D.F. 2012: Psychiatric polypharmacy: hazard through drug-drug-interaction and possibilities for prevention Versicherungsmedizin 64(3): 127-131
Koriakin, V.A.; Sokolova, G.B.; Ziia, A.V.; Zeliger, L.R.; Ivleva, A.Ia. 1987: Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients Terapevticheskii Arkhiv 59(7): 75-77
Gianzi, F.P.; Salamina, G.; Binkin, N.; Lattanzi, A.; Rezza, G. 1993: Study on attitudes and practices of directors of drug addiction treatment centers regarding HIV infection prevention in drug addicts Annali di Igiene: Medicina Preventiva e di Comunita 5(4): 241-245
Takano, A.; Miyamoto, Y.; Kawakami, N.; Matsumoto, T. 2016: The potential of e-Health for treatment and prevention for drug dependence process of development and revision of web-based relapse prevention program "e-SMARPP" Nihon Arukoru Yakubutsu Igakkai Zasshi 51(6): 382-392
Nothdurft, H.D. 1996: Imported malaria: about 1,000 cases per year. Studies of prevention and epidemiology--insufficient drug prevention, emergency medication correctly administered Fortschritte der Medizin 114(35-36): 492-493
Richard, R. Brookman 1985: Rockville, MD National Institute on Drug Abuse, (ADM) 83-1152 ,Adolescent Peer Pressure. Theory, Correlates, and Program Implications for Drug Abuse Prevention (1983) Journal of Adolescent Health Care 6(1): 53-0
Kaverzneva, M.M.; Kondrat'eva, A.P. 1973: Polychemotherapy in lymphogranulomatosis Sovetskaia Meditsina 36(8): 38-42
Rodríguez de la Serna, A.; Díaz-Rubio, M. 1994: Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention Journal of Rheumatology 21(5): 927-933
Gross, R.; Claus, O. 1980: Polychemotherapy - critical examination Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 377-387
Kashuro, V.A.; Glushkov, S.I.; Zheregelia, S.N. 2010: Cytoflavin in polychemotherapy of breast cancer Antibiotiki i Khimioterapiia 55(7-8): 30-33
Spremolla, G.; Papineschi, F.; Caracciolo, F. 1982: Aggressive polychemotherapy in prolymphocytic leukemia Sangre 27(6): 1082-1083